Literature DB >> 29273362

The risk factors of venous thromboembolism in massively transfused patients.

Navpreet K Dhillon1, Eric J T Smith1, Ara Ko1, Megan Y Harada1, Audrey R Yang1, Kavita A Patel1, Galinos Barmparas1, Eric J Ley2.   

Abstract

BACKGROUND: Massive transfusion protocols (MTPs) are necessary for hemodynamically unstable trauma patients with active bleeding. Thrombotic events have been associated with blood transfusion; however, the risk factors for the development of venous thromboembolism (VTE) in trauma patients receiving MTP are unknown.
METHODS: A retrospective review was conducted by reviewing the electronic medical records of all trauma patients admitted to a Level I trauma center who received MTP from 2011 to 2016. Data were collected on patient demographics, mechanism of injury, injury severity scores, quantity of blood products transfused during MTP activation, incidence of VTE, intensive care unit length of stay (LOS), hospital LOS, and ventilator days. The primary outcome was VTE.
RESULTS: Of the 59 patients who had MTP activated, 15 (25.4%) developed a VTE during their hospital admission. Patients who developed VTE were compared with those who did not. Age (40 y versus 35 y, P = 0.59), sex (60% versus 73% male, P = 0.52), and mechanism of injury (47% versus 59% blunt, P = 0.40) were similar. Intensive care unit LOS, hospital LOS, and ventilator days were longer in the patients who were diagnosed with a VTE. Multivariable analysis revealed an increase in the odds for developing a VTE with increasing packed red blood cell transfusion (adjusted odds ratio = 2.61, P = 0.03).
CONCLUSIONS: The risk for VTE in trauma patients requiring massive transfusion is proportional to the number of packed red blood cells transfused. Liberal screening protocols and maintenance of a high index of suspicion for VTE in these high-risk patients is justified.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Deep vein thrombosis; Massive transfusion; Massive transfusion protocol; Trauma; Venous thromboembolism

Mesh:

Year:  2017        PMID: 29273362     DOI: 10.1016/j.jss.2017.09.038

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

1.  Effect of Low-Dose Supplementation of Arginine Vasopressin on Need for Blood Product Transfusions in Patients With Trauma and Hemorrhagic Shock: A Randomized Clinical Trial.

Authors:  Carrie A Sims; Daniel Holena; Patrick Kim; Jose Pascual; Brian Smith; Neils Martin; Mark Seamon; Adam Shiroff; Shariq Raza; Lewis Kaplan; Elena Grill; Nicole Zimmerman; Christopher Mason; Benjamin Abella; Patrick Reilly
Journal:  JAMA Surg       Date:  2019-11-01       Impact factor: 14.766

2.  Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways.

Authors:  Denis F Noubouossie; Michael W Henderson; Micah Mooberry; Anton Ilich; Patrick Ellsworth; Mark Piegore; Sarah C Skinner; Rafal Pawlinski; Ian Welsby; Thomas Renné; Maureane Hoffman; Dougald M Monroe; Nigel S Key
Journal:  Blood       Date:  2020-03-05       Impact factor: 22.113

Review 3.  Transfusion strategies in patients with cirrhosis.

Authors:  Patricia Liu; Justine Hum; Janice Jou; Richard M Scanlan; Joseph Shatzel
Journal:  Eur J Haematol       Date:  2019-11-19       Impact factor: 2.997

Review 4.  Thromboprophylaxis in Intensive Care Unit Patients: A Literature Review.

Authors:  Amna Ejaz; Munis M Ahmed; Azka Tasleem; Muhammad Rafay Khan Niazi; Muhammad Farhan Ahsraf; Imama Ahmad; Asma Zakir; Awais Raza
Journal:  Cureus       Date:  2018-09-21

5.  The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management.

Authors:  Klaus Görlinger; Antonio Pérez-Ferrer; Daniel Dirkmann; Fuat Saner; Marc Maegele; Ángel Augusto Pérez Calatayud; Tae-Yop Kim
Journal:  Korean J Anesthesiol       Date:  2019-05-17

6.  The impact of blood product ratio and procoagulant therapy on the development of thromboembolic events in severely injured hemorrhaging trauma patients.

Authors:  Mathijs R Wirtz; Daisy V Schalkers; J Carel Goslings; Nicole P Juffermans
Journal:  Transfusion       Date:  2020-06-24       Impact factor: 3.157

7.  Perioperative red blood cell infusion and deep vein thrombosis in patients with femoral and pelvic fractures: a propensity score matching.

Authors:  Linqin Wu; Bo Cheng
Journal:  J Orthop Surg Res       Date:  2021-06-05       Impact factor: 2.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.